Former FDA chief Dr. Scott Gottlieb warned that the coronavirus pandemic in the United States will “soon explode” as the country confirmed more than 10 million coronavirus cases on Monday, a bleak milestone just 10 days after hitting the 9 million mark amid a record Increase in daily infections.
On Sunday the country added about 105,000 cases, and Johns Hopkins reported it is the fifth straight day that Covid cases have exceeded 100,000.
“The challenge is that this virus is currently spread across the country,” said Gottlieb. “We are going to see a really significant wave of epidemics across the country and unfortunately it will cause a lot of death and disease before we can do this therapeutic counterattack with not just the vaccine but also.” these therapeutic antibodies. “
Amid the record cases, two groundbreaking developments in the race for a vaccine were announced. The Food and Drug Administration authorized Emergency use of Eli Lilly ‘s experimental antibody treatment for Covid-19 and drug manufacturers Pfizer announced early Data that showed that his experimental vaccine is more than 90% effective in preventing the coronavirus. Albert Bourla, CEO of Pfizer, said CNBC that there could be 50 million cans by the end of the year.
“It’s a great day for science, it’s a great day for humanity,” said Bourla. “When you find that your vaccine is 90% effective, it’s overwhelming.”
In an interview on “The News with Shepard Smith” On Monday evening, Gottlieb explained that deciding who will get the vaccine first, for whom the benefit-risk ratio makes the most sense.
“You want to target more people who will benefit from the vaccine, and that will be older people, likely people in nursing homes or long-term assisted living facilities,” said Gottlieb. “Not only are you at high risk of contracting the virus, but you are also at high risk of getting a bad outcome.”
In a recent NBC News / Wall Street Journal poll, only 20% of people responded that they would get a vaccine as soon as possible, but Dr. Gottlieb told host Shepard Smith that he didn’t think that feeling would last. He stated that there will be a lot more data once the vaccine is ready for the general population, which wouldn’t happen until the second or third quarter of next year.
“The vaccine that gets that level of effectiveness, when we speak of a vaccine being 90% or more effective, really gives you some level of protection that gets you to a point where we can work towards a return a semblance of normal life, maybe later next year when we can make this available to a wider population, “said Gottlieb.